Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Schizophrenia is a chronic, severe brain disorder resulting from gene-environment interactions.
• Symptoms include cognitive, emotional, and behavioral disturbances impacting social functioning.
• Current models link psychosis to dopamine system dysregulation, supported by early antipsychotic discoveries.

Purpose of the Study:

• To explore the pathophysiological concepts linking psychosis to dopamine neurotransmission.
• To discuss molecular mechanisms underlying dopamine dysregulation in schizophrenia.
• To review neuroimaging evidence connecting dopamine disturbances to the clinical phenotype.

Main Methods:

• Review of contemporary pathophysiological models of schizophrenia.
• Analysis of molecular mechanisms related to dopamine neurotransmission.
• Examination of neuroimaging techniques and findings in schizophrenia research.

Main Results:

• Neuroimaging advances have clarified mediator circuits between genetic risk and schizophrenia phenotype.
• Evidence supports dopamine dysregulation as a central mechanism in psychotic symptoms.
• Understanding the link between genetic susceptibility and dopamine pathways is expanding.

Conclusions:

• Dopamine neurotransmission disturbances are critically implicated in the pathophysiology of schizophrenia.
• Modern neuroimaging provides crucial insights into the brain circuits affected in psychosis.
• Further research into dopamine pathways can inform therapeutic strategies for schizophrenia.